Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1997-2002

  Tsuchimori, Noboru ^a,d   Sharkey, Laura L ^b   Fonzi, William A ^b   French, Samuel W ^a,c   Edwards Jr , John E ^a,c   Filler, Scott G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; CANDIDA ALBICANS; CELL ADHESION; CELL DAMAGE; CELL INTERACTION; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; VIRULENCE;

AGAR; ALLELES; ANIMALS; BACTERIAL ADHESION; CANDIDA ALBICANS; CELL ADHESION MOLECULES; CELL DIVISION; ENDOTHELIUM; FUNGAL PROTEINS; GENE DELETION; HOMOZYGOTE; HUMANS; KIDNEY; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MUTAGENESIS, INSERTIONAL; MUTATION; NEUTROPHILS; PHAGOCYTOSIS; SPLEEN; TIME FACTORS; VIRULENCE;

EID: 0034063149     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1997-2002.2000     Document Type: Article

References (27)

1. Csank, C., K. Schröppel, E. Leberer, D. Harcus, O. Mohamed, S. Meloche, D. Y. Thomas, and M. Whiteway. 1998. Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect. Immun. 66:2713-2721.
2. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
3. De Bernardus, F., F. A. Mühlschlegel, A. Cassone, and W. A. Fonzi. 1998. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect. Immun. 66:3317-3325.
4. Edwards, J. E., Jr. 1995. Candida species, p. 2289-2306. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, Inc., New York, N.Y.
5. Filler, S. G., A. S. Pfunder, B. J. Spellberg, J. P. Spellberg, and J. E. Edwards, Jr. 1996. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun. 64:2609-2617.
6. Filler, S. G., J. N. Swerdloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983.
7. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-772.
8. Gale, C. A., C. M. Bendel, M. McClellan, M. Hauser, J. M. Becker, J. Berman, and M. K. Hostetter. 1998. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355-1358.
9. Ghannoum, M. A., S. G. Filler, A. S. Ibrahim, Y. Fu, and J. E. Edwards, Jr. 1992. Modulations of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob. Agents Chemother. 36: 2239-2244.
10. Hube, B., D. Sanglard, F. C. Odds, D. Hess, M. Monod, W. Schafer, A. J. P. Brown, and N. A. R. Gow. 1997. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:3529-3538.
11. Ibrahim, A. S., S. G. Filler, M. A. Ghannoum, and J. E. Edwards, Jr. 1993. Interferon-gamma protects endothelial cells from damage by Candida albicans. J. Infect. Dis. 167:1467-1470.
12. Ibrahim, A. S., S. G. Filler, D. Sanglard, J. E. Edwards, Jr., and B. Hube. 1998. Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect. Immun. 66:3003-3005.
13. Ibrahim, A. S., F. Mirbod, S. G. Filler, Y. Banno, G. T. Cole, Y. Kitajima, J. E. Edwards, Jr., Y. Nozawa, and M. A. Ghannoum. 1995. Evidence implicating phospholipase as a virulence factor in Candida albicans. Infect. Immun. 63:1993-1998.
14. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Ninick. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Investig. 52:2745-2756.
15. Köhler, J. R., and G. R. Fink. 1996. Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc. Natl. Acad. Sci. USA 93:13223-13228.
16. Leberer, E., D. Harcus, I. D. Broadbent, K. L. Clark, D. Dignard, K. Ziegelbauer, A. Schmidt, N. A. R. Gow, A. J. P. Brown, and D. Y. Thomas. 1996. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA 93:13217-13222.
17. Levitz, S. M., D. J. DiBenedetto, and R. D. Diamond. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37-42.
18. Liu, H., J. Köhler, and G. R. Fink. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266:1723-1726.
19. Lo, H.-J., J. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
20. Meshulam, T., S. M. Levitz, K. Christin, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J. Infect. Dis. 172:1153-1156.
21. Noel, R. F., Jr., T. T. Sat, C. Mendez, M. C. Johnson, and T. H. Pohlman. 1995. Activation of human endothelial cells by viable or heat-killed gramnegative bacteria requires soluble CD14. Infect. Immun. 63:4046-4053.
22. Pfaller, M. A., R. N. Jones, G. V. Doern, H. S. Sader, R. J. Hollis, and S. A. Messer. 1998. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J. Clin. Microbiol. 36:1886-1889.
23. Rotrosen, D., J. E. Edwards, Jr., T. R. Gibson, J. D. Moore, A. H. Cohen, and I. Green. 1985. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J. Infect. Dis. 152:1264-1273.
24. Sharkey, L. L., M. D. McNemar, S. M. Saporito-Irwin, P. S. Sypherd, and W. A. Fonzi. 1999. HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J. Bacteriol. 181: 5273-5279.
25. Staab, J. F., S. D. Bradway, P. L. Fidel, and P. Sundstrom. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538.
26. Staab, J. F., C. A. Ferrer, and P. Sundstrom. 1996. Developmental expression of a tandemly repeated, proline- and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. J. Biol. Chem. 271:6298-6305.
27. Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. F. Ernst. 1997. Egf1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 6:1982-1991.